FDA approves Uplizna for treatment of anti-AQP4 antibody–positive NMOSDJune 15, 2020Multiple Sclerosis
Long-term effectiveness of induction vs escalation therapy in relapsing-remitting MSJune 8, 2020Multiple Sclerosis